# A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal

> **NCT05168436** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 105 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05168436
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-05
- **Primary completion:** 2020-07-13
- **Final completion:** 2020-07-13
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168436, "A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05168436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*